796062-33-4

Basic information

• Product Name: 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester
• Synonyms: 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester;3-AMINO-4,4-DIETHOXYPIPERIDINE-1-CARBOXYLIC;3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester oxalate
• CAS NO: 796062-33-4
• Molecular Formula: C14H28N2O4
• Molecular Weight: 288
• EINECS: 1592732-453-0
• Mol File: 796062-33-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester(796062-33-4)
• EPA Substance Registry System: 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester(796062-33-4)

Safety Data

• Hazardous Substances Data: 796062-33-4(Hazardous Substances Data)

Usage

General Description

3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester, also known as DEAC-4, is a chemical compound that belongs to the class of piperidine carboxylic acid esters. It is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 3-Amino-4,4-diethoxypiperidine-1-carboxylic acid tert-butyl ester is a white to off-white crystalline powder that is soluble in organic solvents. It is also stable under normal temperatures and pressures. DEAC-4 is commonly used in the pharmaceutical industry for the production of various drugs and in the agricultural industry for the synthesis of pesticides and herbicides. Due to its versatility and wide range of applications, this compound is of significant interest in the field of organic chemistry.

Upstream product

• 150008-24-5 tert-butyl 4-(hydroxyimino)piperidine-1-carboxylate 
• 917-58-8 potassium ethoxide 
• 141-52-6 sodium ethanolate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 1421503-44-7 4,4-diethoxy-3-{[6-[2-ethyl-5-fluoro-4-(2-trimethylsilanyl-ethoxymethoxy)phenyl]-1-(tetrahydro-pyran-2-yl)-1H-indazole-3-carboximidoyl]amino}piperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF

The present disclosure generally relates to improved synthesis of fused bicyclic Raf inhibitors of formula (I), (I-A), (I-B), (II), or (III), or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof. The disclosure also relates to method o

Design and synthesis of a Pan-Janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin

By use of a structure-based computational method for identification of structurally novel Janus kinase (JAK) inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode. Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in potent pan-JAK inhibitor 2 (PF-06263276), which was advanced into clinical studies.